Results per Page:
Fred Hutch researchers discover molecular switch that helps prostate cancer quickly change its biology to evade therapy
Drs. Andrew Hsieh and Rashmi Mishra identify a key step in the protein-making process that turns a treatable form of prostate cancer into a more lethal, drug-resistant subtype — and a way to switch it back
Sidelining cancer treatment’s side effects through exercise, nutrition, prehab and rehab
In this episode of Bench to Bedside and Beyond, we talk to a prostate cancer survivor and the medical director of Fred Hutch’s cancer rehab about treatment’s aftermath
Fred Hutch researchers receive Prostate Cancer Foundation Young Investigator Awards
Three-year projects explore epigenetics to make new therapies or make existing therapies work better